>>> US Gapping down

Gapping down
In reaction to earnings/guidance:

APPS -18.3%, DT -14.9%, GPRO -11.7%, LITE -11.5%, QLYS -10.1% (also increases buyback auth by $200 mln), PYPL -9.4% (also sees shares repurchases of at least $5 bln in FY24), ACLS -8.8%, CMP -6.9% (also terminates lithium brine project in Utah), RPD -6.6%, PAYC -6.3% (also names new Co-CEO; also to expand in UK), FLT -6.2% (also increases buyback auth by $1 bln), BWA -5.7%, NVST -5.5%, AZN -5.2%, NTGR -5%, TPX -5%, SPGI -4.4%, UHAL -4.3%, EG -3.9%, LNC -3.8%, ORLY -3.7%, MKSI -3.7%, ABG -3.7%, EFX -3.6%, ZBH -3.6%, LSPD -3.4%, CCJ -3.3%, FLNC -3.2%, PYCR -3%, HSY -3%, IPG -3%, PM -2.7%, CXW -2.5%, STE -2.3%, KVUE -2.2%, MCK -2.1%, AXTA -1.7%, MOH -1.5%, ENS -1.1%, HOG -1.1%, CX -1%, SNA -1%

Other news:

TENX -58.5% (Enrolls First Patient in Phase 3 LEVEL Study Evaluating TNX-103) L -3.7% (files mixed shelf securities offering)
AUTL -3.5% (Autolus Therapeutics and BioNTech (BNTX) announce strategic CAR-T Cell therapy collaboration; prices 58333336 American Depositary Shares at a price of $6.00/ADS for total gross proceeds of $350 mln)
ALEC -1.7% (announces first patient dosed in PROGRESS-AD Phase 2 clinical trial of AL101/GSK4527226 in patients with early alzheimer's disease)
CLNE -1.4% (announced the successful completion and operational launch of its latest renewable natural gas production facility at Tri-Cross Dairy in Viborg South Dakota)
COR -0.9% (Walgreens Boots Alliance (WBA) sells shares of Cencora for $992 million of proceeds)

Analyst comments: